Editor's note: This story was revised Feb 11 to include some additional information provided by the Department of Defense.
(CIDRAP News) – After vaccinating more than a million personnel with the old-fashioned type of smallpox vaccine grown on the skin of calves, the US military is about to switch to a second-generation vaccine that's grown in laboratory cell cultures.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) – A second-generation smallpox vaccine made by the British biotechnology company Acambis plc and stockpiled by the US government as protection against bioterrorist attacks has been approved by the US Food and Drug Administration (FDA).
(CIDRAP News) – US officials have announced the award of a $500 million contract to Bavarian Nordic A/S, a Danish firm, for 20 million doses of a smallpox vaccine that's expected to be safe for people with weakened immune systems.